Ambu A/S (CPH:AMBU.B)
Denmark · Delayed Price · Currency is DKK 87.25
+0.30 (0.35%)
At close: Dec 5, 2025
Ambu A/S Market Cap
Ambu A/S has a market cap or net worth of 23.26 billion as of December 5, 2025. Its market cap has decreased by -23.75% in one year.
Market Cap
23.26B
Enterprise Value
22.94B
Revenue
6.04B
Ranking
n/a
PE Ratio
38.27
Stock Price
87.25
Market Cap Chart
Since August 8, 1994, Ambu A/S's market cap has increased from 290.04M to 23.26B, an increase of 7,918.58%. That is a compound annual growth rate of 15.01%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 4, 2025 | 23.18B | -16.34% |
| Dec 30, 2024 | 27.70B | -1.11% |
| Dec 29, 2023 | 28.01B | 23.89% |
| Dec 30, 2022 | 22.61B | -48.49% |
| Dec 30, 2021 | 43.90B | -32.73% |
| Dec 30, 2020 | 65.26B | 138.06% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Novo Nordisk | 1.36T |
| Coloplast | 131.88B |
| Genmab | 127.02B |
| ALK-Abelló | 50.74B |
| Demant | 45.41B |
| H. Lundbeck | 42.14B |
| Zealand Pharma | 35.55B |
| Embla Medical | 15.90B |